Acute myeloid leukemia (AML) is a type of cancer that starts in the bone marrow but can quickly spread to the blood. This condition increases the risk of severe illness and death from COVID-19. The COVID-19 vaccine can lower these risks, but doctors must decide when is the right time for someone with AML to receive it.
Keep reading to learn about the risks of COVID-19, vaccination, and AML.
According to the
People with blood cancers
AML causes some of the same
Consequently, people with AML could experience more intense COVID-19 symptoms than people without AML.
People with AML have a weakened immune system. This is typically a result of the condition, some forms of treatment, or both.
A weakened immune system
AML treatments can weaken the immune system.
For example, chemotherapy uses drugs to kill cancerous cells or prevent them from dividing. It can reduce the number of neutrophils in the blood, which are a type of white blood cell. The immune system is less effective with fewer white blood cells to fight infections.
People with weakened immune systems from these treatments have a
Continue treatment and appointments
People with AML who are receiving treatment should continue attending appointments unless a medical professional advises otherwise.
However, it is important to contact a doctor before each appointment to discuss the risks of visiting a clinic and continuing treatment.
A doctor will decide how to treat AML within the context of COVID-19 on a case-by-case basis.
According to the American Society of Hematology, giving chemotherapy to a person with COVID-19 can carry some risks, as the chemotherapy may interact negatively with the COVID-19 treatment the person is receiving.
Doctors may adjust the intensity and nature of treatment plans for people with AML depending on their individual risks.
According to the
The COVID-19 vaccine is safe for people with cancer, including AML. However, the vaccine may be less effective at preventing COVID-19 in people with weakened immune systems. For this reason, doctors may suggest that some people with AML wait for their immune system to strengthen before they get the vaccine.
There is currently no evidence to suggest that one type of vaccine is safer or more effective than another in people with AML, as none of the current vaccines are live attenuated vaccines.
A guide to different COVID-19 vaccines
- The Pfizer vaccine for coronavirus
- Everything to know about the Moderna COVID-19 vaccine
- How does the Sputnik V COVID-19 vaccine work?
- Oxford-AstraZeneca vaccine: What to know about side effects
- Johnson & Johnson COVID-19 vaccine: What are the side effects?
- Covaxin COVID-19 vaccine: What to know about side effects
All data and statistics are based on publicly available data at the time of publication. Some information may be out of date. Visit our coronavirus hub for the most recent information on COVID-19.
People with AML and other cancers have a
These risks make it essential that people with AML take extra precautions against infection. The
Some tips on protecting against COVID-19 in addition to vaccination
- wearing a tightly fitted face mask
- staying 6 feet, or approximately two arm lengths, away from other people
- avoiding crowds and poorly ventilated locations
- washing the hands and surfaces regularly
- covering coughs and sneezes with an elbow
- staying up to date on local COVID-19 guidance
- checking for COVID-19 symptoms regularly
People with AML, which is a rare type of cancer, have an increased risk of severe illness from COVID-19. This is due to the effects of the condition and some of its treatments.
The COVID-19 vaccine is safe and effective at preventing COVID-19, including in people with cancer. However, the COVID-19 vaccine may be less effective in people with weakened immune systems. People with AML may be undergoing treatments that weaken their immune system.
Doctors may recommend that a person wait for the immune system to strengthen, or suggest changing treatment approaches before the person receives the vaccine.